Garg, Himanshu, Douglas, Maggie, Turkington, Gordon Douglas et al. · BMJ case reports · 2021 · DOI
This small study looked at three patients with severe, long-lasting ME/CFS who had not improved with standard treatments. When doctors added a medication called modafinil to cognitive behavioral therapy (CBT), two of the three patients reported meaningful improvements in fatigue, pain, and concentration, and all three were able to return to work or study. This suggests that combining modafinil with CBT might help some treatment-resistant patients, though more research is needed.
For severely disabled ME/CFS patients who have failed conventional treatments, this case series offers preliminary hope that medication augmentation of psychological therapy might facilitate functional recovery. The findings challenge treatment nihilism in refractory cases and suggest potential value in investigating modafinil as an adjunctive agent in adequately powered trials.
This study does not prove that modafinil causes recovery in ME/CFS, nor does it establish efficacy in the broader patient population. The very small sample size, lack of control or comparison group, retrospective methodology, and potential selection bias mean these findings cannot be generalized. Placebo effects, natural disease trajectory, and other concurrent life changes cannot be excluded as explanations for the observed improvements.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Contribute
Private, reviewed by a human. Not a public comment thread.